$190.00 – $575.00Price range: $190.00 through $575.00
Tirzepatide is a 39-amino acid linear synthetic peptide and dual agonist of the GIP and GLP-1 receptors developed to stimulate glucose-dependent insulin secretion and suppress glucagon through potent activation of the GLP-1R and GIPR signaling pathways. It is utilized in metabolic research examining glucose-lowering mechanisms, gastric emptying kinetics, food intake regulation, and the pharmacokinetic effects of C20 fatty diacid conjugation on albumin-bound peptide half-life.
For research use only. Not for human consumption.
| Select | 10MG, 20MG, 30MG, 60MG |
|---|
Research Applications:
The study of Tirzepatide as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors is primarily relevant to research questions where synergistic metabolic modulation and glucose-dependent glycemic control are the central objectives. Example research contexts include:
Glycemic Homeostasis Models: Investigation of glucose-stimulated insulin secretion (GSIS) and the coordinated suppression of glucagon for the treatment of type 2 diabetes (T2D).
Body Composition and Obesity Studies: Research into reduced food intake and weight loss mediated by the central and peripheral activation of satiety pathways.
Gastric Emptying Kinetics: Models focused on the delay of gastrointestinal transit and its impact on lowering postprandial glucose concentrations.
Long-Acting Peptide Pharmacokinetics: Research regarding fatty acid conjugation (C20 diacid moiety) and its albumin binding properties to prolong plasma half-life.
Because the concept of “dual agonism” proposes efficacy superior to monotherapy, this approach frames metabolic synergy as a hypothesis: if Tirzepatide simultaneously activates the GIPR and GLP-1R, it may overcome the therapeutic bottlenecks of selective agonists (such as insulin resistance or gastrointestinal tolerability). In preclinical designs, this combined administration within a single molecule may produce additive or multiplicative improvements in beta-cell function, insulin sensitivity, and adipose tissue organization—depending on the model choice and specific endpoints.
⚠️ Important Warnings and Disclaimers
Product Guidelines
Product intended for experimental and research purposes only.
Do not use without proper technical knowledge.
Keep refrigerated as per storage guidelines.
Results may vary based on genetics, diet, and lifestyle.
Keep out of reach of children.
Store according to technical instructions.
Do not reuse vials or materials.
Do not purchase if you have any doubts regarding its use.
Limitation of Liability The company is not responsible for:
Misuse or incorrect administration.
Adverse reactions or interactions with other medications.
Consequences resulting from self-medication.
The buyer assumes full responsibility for all risks associated with handling and utilization.
📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.